SOP |
Description |
REDOXS© Specific Procedures |
General Topics (000 Series) |
||
SOP-001 |
A guide for development,
approval and review of standard operating procedures. |
N/A |
SOP-002 |
A guide for development
and review of project specific operating procedures. |
N/A |
SOP-003 |
Describes the research
objectives and the organizational structure of the |
N/A |
Study Setup (200 Series) |
||
SOP-201 |
Describes the process of
delegating and documenting responsibilities of both the sponsor-investigator
at the methods center and the qualified investigator(s) at (a) study site(s) |
|
SOP-202 |
General overview of the
procedures that ensure proper organization and conduct of a clinical study
site. |
N/A |
SOP-204 |
Outline the process for
development, review and approval of written informed consent forms; Define
the content requirements for written informed consent forms; Outline
procedures for research sites to administer informed consent to potential
study participants in compliance with governing regulations. |
|
SOP-205 |
Defines the
investigative site selection process. Outlining the suitability and
qualifications required for site participation in research. |
N/A |
SOP-206 |
Outlines the creation,
review and distribution of Agreements between the |
|
SOP-208 |
Describes procedures for
maintenance, storage and retention of study related documents and records. |
N/A |
Study Implementation and Conduct
(300 Series) |
||
SOP-301 |
Outlines the management
and tracking and investigational product inventory. |
N/A |
SOP-302 |
Outlines the process for
identifying and processing serious adverse event (SAE) information reported
during the conduct of a research study. |
302-R01 |
SOP-303 |
Defines protocol
deviations and violations. Describes procedures for identification,
documentation and follow-up or protocol deviations and violations. |
N/A |
SOP-304 |
To ensure the safety of
study participants and integrity of the study treatment code, this procedure
outlines the algorithm to be followed to determine if study treatment code unblinding is necessary and appropriate, as well as
documentation and follow-up. |
|
SOP-305 |
Describes the process
and documentation of on site monitoring visits. Ensures optimal communication
between the |
N/A |
SOP-306 |
Outlines the process for
assessment of the validity of outcomes for a particular study. |
N/A |
Data Management(400 Series) |
||
SOP-407 |
Outlines the role and
composition of the independent Data Monitoring Committee (DMC) during the
conduct of a clinical trial. |
N/A |
Study Closeout(500 Series) |
||
SOP-501 |
Describes the process
followed when a research study enters the closeout phase. |
N/A |
SOP-502 |
Describes the process
followed in the event that there is an unforeseen termination or suspension
of the study. |
N/A |
SOP-503 |
Guide for facilitating
study closeout for participating research sites. |
N/A |